Book a demo
Skip to content

Stonewake Monitoring

CDT Equity Inc. files 8-K disclosing a new debt obligation

The Delaware pharmaceutical preparations company made a debt-related filing with the SEC on September 18, 2026, its second such filing this month.

Export financeUSAPublished · 3 sourced facts

CDT Equity Inc., a Delaware-incorporated pharmaceutical preparations company listed on Nasdaq under the tickers CDT and CDTTW, filed an 8-K on September 18, 2026.[1][2]

The filing, under accession number 0001493152-26-043398, discloses a debt obligation and covers a period ending September 14, 2026.[1]

The 8-K includes items 1.01, 2.03, 3.02 and 9.01.[1]

It follows an earlier 8-K filed on September 4, 2026, which also disclosed a debt obligation.[3]

Sources

  1. [1]SEC EDGAR: 8-K, 0001493152-26-043398, 18 Sep 2026
  2. [2]SEC EDGAR: CIK 0001896212, CDT Equity Inc.
  3. [3]SEC EDGAR: 8-K, 0001493152-26-041533, 4 Sep 2026

SEC EDGAR

← All briefs